Sante Ventures Invests $2.6M in TVA Medical Inc.

Santé Ventures, a life science venture capital firm, is providing $2.6 million in funding to TVA Medical Inc., a medical device company developing minimally invasive therapies for treatment of end-stage renal disease, according to the companies.

Santé Ventures formed the new company in partnership with TVA founder William Cohn, M.D., a cardiovascular surgeon and the director of minimally invasive surgical technology at the Texas Heart Institute at St. Luke’s Episcopal Hospital in Houston, Texas.

Cohn has more than 60 United States patents awarded or pending for his medical innovations and has been honored as the distinguished inventor of the year by the Intellectual Property Owners Association, according to a statement.

“The partnership with Santé is a very unique opportunity. Santé has committed capital and team resources to this venture, and I am confident that our combined experience and market knowledge provide the right ingredients to build a successful medical device company in TVA, said Cohn.”

With the financing, Adam Berman will join TVA as CEO, and the company will use the funding to complete product development and conduct human clinical trials.